CSF Paraneoplastic Autoantibody Evaluation
Synonyms
LAB11498
PARANCSF
PARANEOPLASTIC AB EVAL, CSF
PARANEOPLASTIC AUTOANTIBODY EVALUATION, SPINAL
Cerner Name
Paraneoplastic AB Eval, CSF
Clinical Info
Aids in the diagnosis of paraneoplastic neurological autoimmune disorders related to carcinoma of lung, breast, ovary, thymoma, or Hodgkin lymphoma in spinal fluid specimens
Specimen Sources
Lumbar Puncture
Specimen Types
Cerebrospinal Fluid
Specimen Volume
4 mL CSF (2 mL min)
Container
Sterile
Collection Instructions
Container/Tube: Sterile vial Specimen : 4 mL CSF (2 mL min) Transport Temperature: Refrigerated Stability: Refrigerated (preferred) - 28 days Frozen - 28 days Ambient - 72 hours
Transport Instructions
Refrigerated
Specimen Stability
Refrigerated (preferred) - 28 days Frozen - 28 days Ambient - 72 hours
Methodology
ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC, AGN1C, NMDIC, AMPIC, GABIC, DPPIC, DPPTC, GL1IC, GL1TC: Indirect Immunofluorescence Assay (IFA) WBNC, ABLTC, CRMWC: Western Blot VGKCC: Radioimmunoassay (RIA) DPPCC, NMDCC, AMPCC, GABCC, GL1CC, LG1CC, CS2CC: Cell-Binding Assay (CBA) GD65C: Immunoprecipitation Assay (IPA)
Days Performed
AGN1C, ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC, AMPIC: Monday through Friday; 11:30 a.m. and 8 p.m.; Saturday, Sunday; 8 a.m. WBNC, CRMWC, ABLTC: Monday, Wednesday, Friday; 8 a.m. NMDCC, AMPCC, GABCC, LG1CC, CS2CC: Monday through Friday; 6 a.m. DPPCC, GL1CC: Monday through Thursday, Sunday; 6 p.m. GD65C: Monday through Friday; 6 a.m. and 4 p.m. VGKCC: Monday through Friday 11 a.m. and 6 p.m.; Saturday, Sunday 6 a.m.
Performing Laboratories
Mayo Medical Laboratories
CPT
86255 x 9 83519 (if appropriate) 84182 x 3 (if appropriate) 86255 x 9 (if appropriate) 86256 x 5 (if appropriate) 86341 (if appropriate) ;
PDM
1659071
Results
Component Name
Base Name
Common Name
External Name
PARANEOPLASTIC INTERPRETATION, CSF
PARAINTCSF
PARANEOPLASTIC INTERPRETATION, CSF
Paraneoplastic Interpretation, CSF
IFA NOTES
IFANOTES
IFA NOTES
IFA Notes
AMPHIPHYSIN AB, CSF
AMPHIPHYABC
AMPHIPHYSIN AB, CSF
Amphiphysin Ab, CSF
ANTI-GLIAL NUCLEAR AB, TYPE 1
GLIALNUCAB1
ANTI GLIAL NUCLEAR AB, TYPE 1
AGNA-1, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 1
ANNAB1
ANTI NEURONAL NUCLEAR AB, TYPE 1
ANNA-1, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 2
ANNAB2
ANTI NEURONAL NUCLEAR AB, TYPE 2
ANNA-2, CSF
ANTI-NEURONAL NUCLEAR AB, TYPE 3
ANNAB3
ANTI NEURONAL NUCLEAR AB, TYPE 3
ANNA-3, CSF
CRMP-5-IGG, CSF
CRMP5IGGCSF
CRMP 5 IGG, CSF
CRMP-5-IgG, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE 1
PURCYTO1
PURKINJE CELL CYTOPLASMIC AB TYPE 1
PCA-1, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE 2
PURCYTO2
PURKINJE CELL CYTOPLASMIC AB TYPE 2
PCA-2, CSF
PURKINJE CELL CYTOPLASMIC AB TYPE TR
PURCYTOTR
PURKINJE CELL CYTOPLASMIC AB TYPE TR
PCA-Tr, CSF
Result Interpretation
See Report and Algorithum
Forms
Immunology
LAB11498